Immunohistochemistry (IHC) analysis confirmed the results, showing an increase of IGF1 and a decrease of IGF1R in the PCOS group and a recovery of values in response to RES treatment (Figure 1I). The gene discussed is IGF1; the disease is polycystic ovary syndrome.